Rankings
▼
Calendar
RLAY Q2 2024 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$101M
Net Income
-$92M
EPS (Diluted)
$-0.69
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$66M
Free Cash Flow
-$66M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$773M
Total Liabilities
$91M
Stockholders' Equity
$682M
Cash & Equivalents
$134M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$119,000
-100.0%
Gross Profit
$0
-$88M
+100.0%
Operating Income
-$101M
-$106M
+5.0%
Net Income
-$92M
-$99M
+6.4%
← FY 2024
All Quarters
Q3 2024 →